Company Overview - Codexis, Inc. is a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics [3] - The company leverages its proprietary CodeEvolver® technology platform to discover, develop, and enhance novel, high-performance enzymes [3] - Codexis is developing its proprietary ECO Synthesis® manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route [3] Upcoming Events - Codexis will attend the Cantor Global Healthcare Conference from September 3-5, 2025, in New York, New York [1] - Management will participate in a fireside chat on September 4, 2025, at 3:55 pm ET, with a live webcast available on the company's Investor Relations website [2]
Codexis to Participate in Cantor Global Healthcare Conference